Enflonsia

Active Ingredient(s): Clesrovimab-cfor
FDA Approved: * June 9, 2025
Pharm Company: * MERCK SHARP DOHME
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Enflonsia 150 mg/ml Intramuscular Injection, Solution
NDC: 0006-5073
Labeler:
Merck Sharp & Dohme LLC